Quality Improvement Initiative to Reduce Admissions for Nephrotic Syndrome Relapse in Pediatric Patients

Olga Charnaya1, Sun-Young Ahn1,2

  • 1Division of Nephrology, Children's National Health System, Washington, DC, United States.

Insights

A standardized education program for childhood nephrotic syndrome (NS) reduced hospital admissions for relapse. This quality improvement initiative improved patient safety and decreased healthcare costs by enabling more outpatient management.

Area of Science:

  • Pediatric Nephrology
  • Quality Improvement Initiatives
  • Patient Education

Background:

  • Childhood nephrotic syndrome (NS) frequently requires hospitalization for management.
  • Effective outpatient care for NS complications can reduce healthcare costs and improve patient safety.
  • Timely recognition of NS relapse is crucial for successful outpatient management.

Purpose of the Study:

  • To reduce hospital admissions for nephrotic syndrome relapse from 8 to fewer than 5 admissions within a 3-month period.
  • To identify and overcome barriers to early recognition of NS relapse and outpatient care.
  • To implement and evaluate a standardized patient and family education program for idiopathic nephrotic syndrome.

Main Methods:

  • Fish-bone analysis identified patient education as a key barrier to early relapse recognition.
  • A standardized educational approach and materials were developed and disseminated by stakeholder champions.
  • Admission counts were compared pre- and post-implementation, with clinic visits and patient surveys as balancing and process measures.

Main Results:

  • Hospital admissions for NS relapse initially decreased, meeting the goal for the first three quarters.
  • Admission counts exceeded the target in the final quarter of the study period.
  • 75-80% of families reported receiving nephrotic syndrome education, indicating successful implementation of the educational process.

Conclusions:

  • Standardized patient and family education effectively reduces hospital admissions for idiopathic nephrotic syndrome relapse.
  • Improved outpatient management of NS relapse leads to reduced healthcare expenditure.
  • Enhancing patient and family education is vital for improving patient safety in childhood nephrotic syndrome.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
554
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
231
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
309
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203